Management of newly diagnosed single brain metastasis with surgical resection and permanent I-125 seeds without upfront whole brain radiotherapy

J Neurooncol. 2009 May;92(3):393-400. doi: 10.1007/s11060-009-9868-6. Epub 2009 Apr 9.

Abstract

In this retrospective study, we evaluate the efficacy of surgical resection and I-125 seeds, without upfront whole brain radiotherapy (WBRT), for newly diagnosed single brain metastasis. About 40 women and 32 men underwent gross total resection and placement of permanent low-activity I-125 seeds at our institution (1997-2007). Primary systemic cancer sites varied. At follow-up (median 16 months), local control rate was 93%. Distant brain failures occurred in 23 (32%) patients: 5 patients within 3 months and 18 patients >3 months; brain failure underwent further treatment (i.e., radiosurgery in 13, WBRT in 5, surgical resection with I-125 seeds in 2). Four patients developed radiation necrosis. All 72 patients had stable or improved Karnofsky Performance Score at 1 month after surgery. Median actuarial survival rate was 14 months; 2-year survival rate was 27%. Permanent I-125 brachytherapy at initial operation without WBRT provided excellent local control. 67 patients (93%) never required WBRT, thus avoiding potential long-term radiation-induced neurotoxicity.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Brachytherapy*
  • Brain Neoplasms / radiotherapy*
  • Brain Neoplasms / secondary*
  • Brain Neoplasms / surgery*
  • Combined Modality Therapy
  • Cranial Irradiation
  • Female
  • Humans
  • Iodine Radioisotopes / therapeutic use*
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Neurosurgical Procedures
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Iodine Radioisotopes